Aspen Aerogels, Inc.
US ˙ NYSE ˙ US04523Y1055

SecurityASPN / Aspen Aerogels, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in ASPN / Aspen Aerogels, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Aspen Aerogels, Inc. (US:ASPN) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,083 shares of Aspen Aerogels, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ASPEN AEROGELS COM 04523Y105 0 -100.00 0
2026-02-05 2025-12-31 13F ASPEN AEROGELS COM 04523Y105 2,083 -47 -2.21 0 0.0000
2025-10-29 2025-09-30 13F ASPEN AEROGELS COM 04523Y105 2,130 0 0.00 0 0.0001
2025-08-04 2025-06-30 13F ASPEN AEROGELS COM 04523Y105 2,130 0 0.00 0 0.0001
2025-04-25 2025-03-31 13F ASPEN AEROGELS COM 04523Y105 2,130 386 22.13 0 0.0001
2025-02-04 2024-12-31 13F ASPEN AEROGELS COM 04523Y105 1,744 0 0.00 0 0.0002
2024-10-30 2024-09-30 13F ASPEN AEROGELS COM 04523Y105 1,744 0 0.00 0 0.0004
2024-08-12 2024-06-30 13F ASPEN AEROGELS COM 04523Y105 1,744 0 0.00 0 0.0004
2024-04-23 2024-03-31 13F ASPEN AEROGELS COM 04523Y105 1,744 -2,735 -61.06 0 0.0003
2024-02-06 2023-12-31 13F ASPEN AEROGELS COM 04523Y105 4,479 499 12.54 0 0.0006
2023-11-08 2023-09-30 13F ASPEN AEROGELS COM 04523Y105 3,980 0 0.00 0 0.0003
2023-08-11 2023-06-30 13F ASPEN AEROGELS COM 04523Y105 3,980 -2,015 -33.61 0 0.0003
2023-05-02 2023-03-31 13F ASPEN AEROGELS COM 04523Y105 5,995 1,200 25.03 0 0.0004
2023-02-10 2022-12-31 13F ASPEN AEROGELS COM 04523Y105 4,795 0 0.00 0 -100.00 0.0005
2022-11-09 2022-09-30 13F ASPEN AEROGELS COM 04523Y105 4,795 455 10.48 44 2.33 0.0004
2022-08-15 2022-06-30 13F ASPEN AEROGELS COM 04523Y105 4,340 750 20.89 43 -65.32 0.0004
2022-08-25 2022-03-31 13F/A-1 ASPEN AEROGELS COM 04523Y105 3,590 3,590 124 0.0010
2022-06-30 2022-03-31 13F ASPEN AEROGELS COM 04523Y105 3,590 3,590 124 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.